Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases

C. Felice, A. Lewis, Alessandro Armuzzi, J. O. Lindsay, A. Silver

Research output: Contribution to journalArticle

69 Citations (Scopus)

Abstract

A link between histone deacetylases (HDACs) and intestinal inflammation has been established. HDAC inhibitors that target gut-selective inflammatory pathways represent a potential new therapeutic strategy in patients with refractory inflammatory bowel diseases (IBD).
Original languageEnglish
Pages (from-to)26-38
Number of pages13
JournalALIMENTARY PHARMACOLOGY & THERAPEUTICS
Volume41
DOIs
Publication statusPublished - 2014

Keywords

  • inflammatory bowel disease
  • therapeutic targets

Fingerprint

Dive into the research topics of 'Review article: selective histone deacetylase isoforms as potential therapeutic targets in inflammatory bowel diseases'. Together they form a unique fingerprint.

Cite this